|
The oral insulin new drug labelled as IN-105 is in an advanced stage of research and hopefully within the next 3-4 years this drug could become a reality and it will be a huge recognition of innovation for an Indian company.MS KIRAN Mazumdar Shaw, Chairman and Managing Director of Biocon, India, has gone on record saying that if everthing goes well with her company's Research & Development activities,...
|
